For the year ending 2025-12-31, MRKR made $3,546,669 in revenue. -$12,163,620 in net income. Net profit margin of -342.96%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 3,546,669 | 6,591,080 | ||
| Research and development | 11,799,154 | 13,467,845 | ||
| General and administrative | 4,184,806 | 4,241,607 | ||
| Loss on early termination of vendor agreement | -453,135 | - | ||
| Total operating expenses | 16,437,095 | 17,709,452 | ||
| Loss from operations | -12,890,426 | -11,118,372 | ||
| Interest income | 594,206 | 437,010 | ||
| Other income | 117,444 | - | ||
| Loss from operations before income taxes | -12,178,776 | -10,681,362 | ||
| Income tax (benefit) expense | -15,156 | 49,953 | ||
| Net loss from continuing operations | - | -10,731,315 | ||
| Net loss | -12,163,620 | -10,731,315 | ||
| Basic EPS | -0.79 | -1.19 | ||
| Diluted EPS | -0.79 | -1.19 | ||
| Basic Average Shares | 15,310,308 | 8,980,207 | ||
| Diluted Average Shares | 15,310,308 | 8,980,207 | ||
Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc. (MRKR)